You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

CLINICAL TRIALS PROFILE FOR CYTISINICLINE

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Cytisinicline

Subscribe to access the full database, or Get Started Free
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT03848208 ↗	A Single Dose-escalation Study of Cytisine in Adult Smokers	Completed	Achieve Life Sciences	Phase 1	The objectives of this study are: 1. To assess the tolerability and safety of cytisine as a single oral dose. 2. To define the Cmax levels associated to the occurrence of dose-limiting adverse events.
NCT04576949 ↗	A Study of Cytisinicline for Smoking Cessation in Adult Smokers	Active, not recruiting	Achieve Life Sciences	Phase 3	This placebo-controlled Phase 3 study is being conducted at sites within the United States to evaluate 3 mg cytisinicline TID for treatment duration of 42 days/6 weeks as well as repeating that duration for a total of 84 days/12 weeks treatment.
NCT05206370 ↗	A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers	Not yet recruiting	Achieve Life Sciences	Phase 3	This placebo-controlled Phase 3 study is being conducted at sites within the United States to evaluate 3 mg cytisinicline TID for treatment duration of 42 days/6 weeks as well as repeating that duration for a total of 84 days/12 weeks treatment.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Cytisinicline

Condition Name

Chart
Table

Condition Name
Intervention	Trials
Smoking Cessation	7
Vaping	1
Vaping Cessation	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH
Intervention	Trials
Smoking Cessation	2
Cigarette Smoking	1
Renal Insufficiency	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Cytisinicline

Trials by Country

Map
Table

Trials by Country
Location	Trials
United States	44
Portugal	5
Spain	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State
Location	Trials
New York	3
Tennessee	3
Nevada	2
Missouri	2
Massachusetts	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Cytisinicline

Clinical Trial Phase

Chart
Table

Clinical Trial Phase
Clinical Trial Phase	Trials
PHASE3	1
PHASE2	1
Phase 3	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status
Clinical Trial Phase	Trials
Not yet recruiting	4
Completed	2
ACTIVE_NOT_RECRUITING	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cytisinicline

Sponsor Name

Chart
Table

Sponsor Name
Sponsor	Trials
Achieve Life Sciences	8
University of California, Los Angeles	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type
Sponsor	Trials
Industry	8
OTHER	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.